※ 출처: ClinicalTrials.gov
총 236건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 ZIP Study - A Study to Evaluate the PK, Safety, Efficacy, and PD With ATB200/AT2221 in LOPD Subjects Aged 12 to <18 Pompe Disease (Late-onset) Biological: ATB200|Drug: AT2221 Amicus Therapeutics Phase 3 2020-02-13
2 A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma Renal Cell Carcinoma Biological: Nivolumab|Biological: Ipilimumab Bristol-Myers Squibb Phase 2 2020-01-31
3 Validation of the In-utero Transmission of Probiotics In Utero Drug Exposure Biological: Natural products: Probiotics|Other: Placebo Centre de recherche du Centre hospitalier universitaire de Sherbrooke|Lallemand Health Solutions Phase 2 2020-01-30
4 A Study of Nivolumab Plus NKTR-214 vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer. Bladder Cancer|Bladder Tumor|Muscle-Invasive Bladder Cancer Biological: Nivolumab|Biological: NKTR-214|Procedure: Radical cystectomy (RC) Bristol-Myers Squibb|Nektar Therapeutics Phase 3 2020-01-23
5 Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning Prostate Cancer Drug: Pembrolizumab CHU de Quebec-Universite Laval|Merck Sharp & Dohme Corp. Phase 2 2020-01-10
6 A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation Carcinoma, Hepatocellular Drug: Atezolizumab|Drug: Bevacizumab Hoffmann-La Roche Phase 3 2019-12-31
7 Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc) Diffuse Cutaneous Systemic Sclerosis Biological: IgPro10|Biological: Placebo CSL Behring Phase 2 2019-12-20
8 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009) Triple Negative Breast Neoplasms Biological: Pembrolizumab|Drug: Olaparib|Drug: Carboplatin|Drug: Gemcitabine Merck Sharp & Dohme Corp. Phase 2|Phase 3 2019-12-19
9 A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response Herpes Zoster Biological: HZ/su vaccine (GSK1437173A) GlaxoSmithKline Phase 3 2019-12-09
10 A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) Bladder Cancer Drug: nivolumab|Other: Placebo|Biological: Bacillus Calmette-Guérin (BCG) Bristol-Myers Squibb Phase 3 2019-12-09